Chiara Naro - Concepedia

Author

Chiara Naro

Università Cattolica del Sacro Cuore ORCID

Also Known As

C Naro, Chiara Naro, NARO, CHIARA, Naro, Chiara

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia University of Rome Tor Vergata Agostino Gemelli University Polyclinic

About

Chiara Naro is an author at Università Cattolica del Sacro Cuore specializing in cell biology, medicine, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	103
2	Cell Biology	4	4	103
3	Natural Sciences	1	1	17
4	Biochemistry	1	1	17
5	Immunology	1	1	34

Chiara Naro

Publications

541

Citations

H-Index

Page 1

	Year	Citations
An Orchestrated Intron Retention Program in Meiosis Controls Timely Usage of Transcripts during Germ Cell Differentiation Chiara Naro, Ariane Jolly, Sara Di Persio, Developmental Cell	2017	184
The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival Chiara Naro, Federica Barbagallo, Paolo Chieffi, Nucleic Acids Research	2013	90
Functional Interaction between U1snRNP and Sam68 Insures Proper 3′ End Pre-mRNA Processing during Germ Cell Differentiation Chiara Naro, Livia Pellegrini, Ariane Jolly, Cell Reports	2019	44
Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4+ T lymphocytes Alessandro Comandini, Chiara Naro, Riccardo Adamo, Molecular Immunology Human RetrovirusTelomerase ActivityT-regulatory CellImmunologyAntiviral Response	2012	34
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum Donatella Farini, Eleonora Cesari, Robert J. Weatheritt, Cell Reports	2020	34
The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells Chiara Naro, Monica De Musso, Francesca Delle Monache, Journal of Experimental & Clinical Cancer Research	2021	33
The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma Valentina Panzeri, Isabella Manni, Alessia Capone, Molecular Oncology OncologyPdac PathologyPancreatic CancerPrognostic FactorMedicine	2020	32
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer Veronica Ruta, Chiara Naro, Marco Pieraccioli, Cell Reports Medicine	2024	23
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer Chiara Naro, Federica Barbagallo, Cinzia Caggiano, Frontiers in Oncology MedicineReceptor Tyrosine KinaseCancer Cell BiologyOncogenic Kinase Nek2Cancer Genomics	2022	20
Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis Eleonora Cesari, Maria Loiarro, Chiara Naro, Cell Death and Disease	2020	19

Page 1